Delivery Order SPE2DB24D2205-SPE2DB25FDXRS
Award Date
1/30/25
Potential Completion Date
1/31/25
Potential Value
$36K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $41,267.12, was awarded to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distribution company. This is a firm fixed-price delivery order contract with an ultimate completion date of April 22, 2024. The contract does not have a set-aside designation....
The federal contract award is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price type, valued at $62,258.80, and has an ultimate completion date of January 30, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not designated with any set-aside requirements, indicating open...
The federal contract award is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML medication to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $2,630.88 and is a firm fixed-price delivery order with an ultimate completion date of October 28, 2024. The contract is not designated as a set-aside. In addition to this specific delivery order,...
This federal contract award is for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $17,695.04, was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. (doing business as Amerisourcebergen), as a firm fixed-price delivery order. This award is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $25,192.00, is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialty pharmaceutical product. The contract is a Delivery Order awarded under an Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and running through...
This federal contract award, valued at $30,884.63, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialty pharmaceutical product, to support military treatment programs and facilities. This contract award is a delivery order under a larger indefinite delivery contract (IDC)...
This federal contract award, with a ceiling value of $11,012.56, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp. The contract is for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a pharmaceutical product, to support military treatment facilities and healthcare programs. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of August 22, 2024. Amerisourcebergen, a major pharmaceutical...
This federal contract award is to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialty medication. The contract has a ceiling value of $13,213.09 and was awarded by the Defense Logistics Agency (DLA), a defense agency. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of December 23, 2024. The contract is not designated with a...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, with a ceiling value of $15,236.93 and a completion date of October 11, 2023. The contract type is a Delivery Order under a Firm Fixed Price pricing arrangement. The contract is not designated as a set-aside....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $46,649.47 firm-fixed-price delivery order is for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialty medication. The contract has an ultimate completion date of October 17, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...